Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–50 of 59 results
Advanced filters: Author: Sarah DeWeerdt Clear advanced filters
  • Sarah DeWeerdt describes the intricate relationship between HIV and the host immune system, each influencing the other's next moves.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 466, P: S6-S7
  • The search for disease mechanisms and treatments is one of the biggest collaborative efforts in science. These researchers are significant contributors.

    • Sarah DeWeerdt
    • Mark Zastrow
    • Gemma Conroy
    Special Features
    Nature
    Volume: 580, P: S24-S27
  • Increasing the amount of protein produced through aquaculture is essential to feed a growing global population. But scientists want to ensure the industry grows sustainably.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 588, P: S60-S62
  • The characteristic brain pathology and motor symptoms of Parkinson's disease are well established. But the details of the disease's cause and course are much murkier.

    • Sarah Deweerdt
    Comments & Opinion
    Nature
    Volume: 538, P: S17
  • Plastic has long been an ecological problem. But emerging technologies and more awareness could make the ubiquitous material part of a circular economy.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 611, P: S2-S5
  • Gene exploration is providing unexpected insights into inflammatory bowel disease, and getting scientists closer to finding treatments that target the biological mechanisms.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 540, P: S104-S105
  • Disrupted sleep patterns affect mental health, and researchers now hope that repairing circadian rhythms could ease symptoms.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 608, P: S50-S51
  • Researchers are amassing evidence about the best ways to treat the precursor condition before it develops into active disease.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 587, P: S58-S59
  • Vaccination is picking up where screening left off to reduce the incidence of one of the most common cancers in women.

    • Sarah DeWeerdt
    Special Features
    Nature
    Volume: 580, P: S2-S4
  • Even as new treatments loom, researchers are still trying to understand what goes wrong inside the cells of people with the genetic disorder.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 557, P: S36-S37
  • The increasing acidity of our seas is a threat to marine life that for many species may be impossible to overcome.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 550, P: S54-S58
  • A subterranean species that seems to be cancer-proof is providing promising clues on how we might prevent the disease in humans.

    • Sarah Deweerdt
    Comments & Opinion
    Nature
    Volume: 509, P: S60-S61
  • A pathogen spread by domestic cats threatens the health of humans and livestock. Could a solution as simple as taking better care of cats help to combat the infection?

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 543, P: S52-S53
  • Many people with irritable bowel syndrome feel that they benefit from dietary interventions, but researchers still lack a full understanding of how food can inflame this disorder.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 533, P: S108-S109
  • As the fallopian tubes come to the fore as the source of the most common form of ovarian cancer, researchers and clinicians are devising strategies to prevent the disease.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 600, P: S42-S44
  • Access to fertility treatments is limited by the cost in both high- and low-income countries. But new technologies and attitudes aim to fix that.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 588, P: S174-S176
  • Anti-inflammatory therapies for cardiovascular disease are nearing the clinic. But whether scientists understand how inflammation contributes to fatty-deposit build-up well enough to target it effectively is open to debate.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 594, P: S8-S9
  • A flood of sequencing data is enabling researchers to uncover how tumours differ from each other, and what such variation means for treatment strategies.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 561, P: S54-S55
  • Eating well could be better for skin health than applying lotions and potions. But which vitamins and nutrients will yield the healthiest glow?

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 563, P: S94-S95
  • Treatments that target RNA or deliver it to cells fall into three broad categories, with hybrid approaches also emerging.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 574, P: S2-S3
  • William Coley found a way to prompt the immune system to fight cancer over a century ago. After years of neglect, scientists are now seeking to replicate his success.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 504, P: S4-S5
  • Researchers are on the hunt for a better alternative to the BCG vaccine.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 502, P: S8-S9
  • As the link between stress and psoriasis flare-ups becomes clearer, it seems the most vulnerable patients require a new type of treatment.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 492, P: S62-S63
  • Treatments that can cross the blood–brain barrier are needed if doctors are to treat the devastating neurological symptoms of many lysosomal storage disorders.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 537, P: S154-S157
  • Introducing a human disease into mice is helping researchers explore its nature and find potential therapies.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 480, P: S38-S39
  • Transporting people around the cities of the future is a public-policy challenge, but it's also an opportunity to improve the health of urban populations.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 531, P: S52-S53
  • Gut bacteria have an important but elusive role in the formation of colorectal cancer.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 521, P: S10-S11
  • Technologies that rapidly sequence DNA reveal deep genetic diversity both within and among individuals with leukaemia.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 498, P: S4-S6
  • Studies in never-smokers have revealed key lung-cancer mutations — but the cause of the disease is still a mystery.

    • Sarah Deweerdt
    Comments & Opinion
    Nature
    Volume: 513, P: S12-S13
  • Finding the right food to help reduce our chances of cancer can be a maze. But ongoing studies and a little inventive cooking might point us in the right direction.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 471, P: S22-S24
  • The study of autism around the globe must account for a variety of behavioural norms in different societies.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 491, P: S18-S19
  • The nearly century-long search for a malaria vaccine might end in the bottom of a cup.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 484, P: S24-S25
  • The causal relationships between lack of sleep and mood disorders remain murky. But one thing is clear as day: better sleep can have psychological benefits.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 497, P: S14-S15
  • In type 1 diabetes, the immune system goes haywire and depletes insulin-producing cells. Drugs that interfere with this process could one day reverse the disease's course.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 485, P: S4-S5
  • Can exercise, social interaction and the Mediterranean diet really help to keep the cognitive decline of Alzheimer's disease at bay?

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 475, P: S16-S17
  • State-of-the art tumour-genome sequencing and analysis is enabling researchers to provide uniquely personalized immunotherapy.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 552, P: S76-S77
  • Work to determine which prostate cancers are truly dangerous may finally be coming to fruition.

    • Sarah Deweerdt
    Comments & Opinion
    Nature
    Volume: 528, P: S124-S125
  • Results ready in minutes and more efficacious drugs will help find and treat the hundreds of millions of carriers.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 474, P: S20-S21
  • Treatments for olfactory loss are currently scarce, but with millions of people unable to smell as a result of COVID-19, researchers are pursuing the problem with renewed vigour.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 606, P: S7-S9
  • Understanding how the opioid epidemic arose in the United States could help to predict how it might spread to other countries.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 573, P: S10-S12
  • To predict how much climate change will raise sea level, researchers are studying ice shelves — where vast expanses of ice meet the ocean.

    • Sarah DeWeerdt
    Comments & Opinion
    Nature
    Volume: 575, P: S2-S5